Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Two or more cell types – per se – in co-culture
Reexamination Certificate
2010-02-17
2011-12-20
Belyavskyi, Michail (Department: 1644)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Two or more cell types, per se, in co-culture
C435S372200, C435S372300, C435S372000
Reexamination Certificate
active
08080416
ABSTRACT:
The present invention relates to methods for preparing an artificial immune system. The artificial immune system comprises a cell culture comprising T cells, B cells and antigen-primed dendritic cells. The artificial immune system of the present invention can be used for in vitro testing of vaccines, adjuvants, immunotherapy candidates, cosmetics, drugs, biologics and other chemicals.
REFERENCES:
patent: 5008116 (1991-04-01), Cahn
patent: 5160490 (1992-11-01), Naughton et al.
patent: 5354686 (1994-10-01), Haberman
patent: 5562910 (1996-10-01), Daynes et al.
patent: 5725856 (1998-03-01), Hudziak et al.
patent: 5739001 (1998-04-01), Brown et al.
patent: 5750329 (1998-05-01), Quinn et al.
patent: 6177282 (2001-01-01), McIntyre
patent: 6274378 (2001-08-01), Steinman et al.
patent: 6479064 (2002-11-01), Atala
patent: 6541225 (2003-04-01), Li
patent: 6835550 (2004-12-01), Estell et al.
patent: 7709257 (2010-05-01), Tew et al.
patent: 2002/0155108 (2002-10-01), Barbera-Guillem et al.
patent: 2003/0109042 (2003-06-01), Wu et al.
patent: 2003/0147923 (2003-08-01), Klaviniskis
patent: 2003/0199006 (2003-10-01), Britz et al.
patent: 2003/0207287 (2003-11-01), Short
patent: 2004/0009943 (2004-01-01), Semple et al.
patent: 2004/0109876 (2004-06-01), Yamamoto et al.
patent: 2004/0234510 (2004-11-01), Mochitate
patent: 2005/0191743 (2005-09-01), Wu et al.
patent: 2005/0229264 (2005-10-01), Chang et al.
patent: 2005/0282148 (2005-12-01), Warren et al.
patent: 2006/0078540 (2006-04-01), Warren et al.
patent: 2006/0105454 (2006-05-01), Son et al.
patent: 2006/0270029 (2006-11-01), Warren et al.
patent: 2006/0275270 (2006-12-01), Warren et al.
patent: 2007/0015136 (2007-01-01), Sanchez-Schmitz et al.
patent: 2007/0141552 (2007-06-01), Warren et al.
patent: 2007/0154956 (2007-07-01), Warren et al.
patent: 2007/0178076 (2007-08-01), Drake et al.
patent: 2007/0218054 (2007-09-01), Sukumar et al.
patent: 2008/0008653 (2008-01-01), Tew et al.
patent: 2009/0011455 (2009-01-01), Warren et al.
patent: 2009/0104221 (2009-04-01), El Shikh et al.
patent: 2009/0117581 (2009-05-01), Warren et al.
patent: 0358506 (1989-09-01), None
patent: 1013668 (2000-06-01), None
patent: 1437147 (2002-09-01), None
patent: 1970444 (2006-12-01), None
patent: 99/12972 (1999-03-01), None
patent: WO 99/15629 (1999-04-01), None
patent: WO 99/43788 (1999-09-01), None
patent: WO 99/49319 (1999-09-01), None
patent: WO 03/041568 (2003-05-01), None
patent: WO 03/050271 (2003-06-01), None
patent: WO 2004/031361 (2004-04-01), None
patent: WO 2004/101773 (2004-11-01), None
patent: 2005/013896 (2005-02-01), None
patent: 2005/072088 (2005-08-01), None
patent: WO 2005/104755 (2005-11-01), None
patent: WO 2007/075979 (2007-07-01), None
patent: 2007/108835 (2007-09-01), None
patent: WO 2007/106559 (2007-09-01), None
patent: WO 2007/146267 (2007-12-01), None
Buchler et al ., Vaccine, 2003, v.21, pp. 877-882).
Ansel, et al., “A Chemokine-Driven Positive Feedback Loop Organizes Lymphoid Follicles”, Nature, vol. 406, pp. 309-314 (2000).
Aydar et al. (2005)J. Immunol. 174, 5358-5366.
Badylak, S.F. et al., “Small Intestinal Submucosa: A Substrate for in vitro Cell Growth,” J. Biomater. Sci. Polymer Edn. (1998), vol. 9, No. 8, pp. 863-878.
Bai et al., “Generation of Dendritic Cells From Human Bone Marrow Mononuclear Cells: Advantages From Clinical Applications in Comparison to Peripheral Blood Monocyte Derived Cells,” International Journal of Oncology, (2002), 20(2), pp. 247-253.
Banchereau, et al., “Dendritic Cells and the Control of Immunity”, Nature, vol. 392, pp. 245-252 (1998).
Banchereau, et al., “Immunobiology of Dendritic Cells”, Annu. Rev. Immunol., vol. 18, pp. 767-811 (2000).
Baumgarth, “A Two-Phase Model of B-Cell Activation”, Immunological Review, vol. 176, pp. 171-180 (2000).
Benbrook et al., “Organotypic cultures represent tumor microenvironment for drug testing,” Drug Discovery Today: Disease Models, 3(2), pp. 143-148 (2005).
Berman, et al., “Roles of Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1, CD31) in Natural Killer Cell Transendothelial Migration and Beta 2 Integrin Activation”, The Journal of Immunology, vol. 156, pp. 1515-1524 (1996).
Birkness et al., A Tissue Culture Bilayer Model to Study the Passage ofNeisseria meningitidis, Infection and Immunity, Feb. 1995, p. 402-409, vol. 63, No. 2.
Birkness et al., An In Vitro Tissue Culture Bilayer Model to Examine Early Events inMycobacterium tuberculosisInfection,Infection and Immunity, Feb. 1999, p. 653-658, vol. 67, No. 2.
Bogdan, et al., “Fibroblasts as Host Cells in Latent Leishmaniosis”,J. Exp. Med., vol. 191, pp. 2121-2129 (2000).
Boni et al. (2006)Eur. J. Immunol. 36, 3157-3166.
Brandtzaeg, P. et al., “Mucosal B Cells: Phenotypic Characteristics, Transcriptional, Regulation, and Homing Properties,” Immunological Reviews (2005), vol. 206, pp. 32-63.
Bromelow, K. V. et al., “Whole Blood Assay for Assessment of the Mixed Lymphocyte Reaction,” Journal of Immunological Methods, (2001), 247(1-2), pp. 1-8.
Büchele, S. et al., “Presentation of Tetanus Toxoid to Autologous T Cells by Dendritic Cells Generated From Human Blood. Improved Specificity With Dendritic Cells Generated Without Fetal Calf Serum,” Advances in Experimental Medicine and Biology, (1997), vol. 417, pp. 233-237.
Buchler et al. (2003)Vaccine, 21, 877-882.
Butcher, et al., “Lymphocyte Trafficking and Regional Immunity”, Advances in Immunology, vol. 72, pp. 209-253 (1999).
Castro, et al., “Spleen-Derived Stromal Cells. Adhesion Molecules Expression and Lymphocyte Adhesion to Reticular Cells”, Eur. J. Cell. Biol., vol. 74, 321-328 (1997).
Caux et al. (1995)J. Immunol. 155, 5427-5435.
Cayeux et al. (1999)Eur. J. Immunol. 29, 225-234.
Chen, et al., “A Film Tension Theory of Phagocytosis”, Journal of Colloid and Interface Science, vol. 190, pp. 118-133 (1997).
Chou, et al., “The Detection of the HLA-B27 Antigen by Immunomagnetic Separation and Enzyme-Linked Immunosorbent Assay-Comparison with a Flow Cytometric Procedure”, Journal of Immunological Methods, vol. 255, pp. 15-22 (2001).
Clayton et al., Clin. Exp. Immunol., 2003, v.132, p. 174-179.
Crivellato, et al., “Stromal Cell Organisation in the Mouse Lymph Node. A Light and Electron Microscopic Investigation Using the Zinc Iodide-Osmium Technique”, J. Anat., vol. 190, pp. 85-92 (1997).
Cyster, “Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs”, J. Exp. Med. vol. 189, No. 3, pp. 447-450 (1999).
Cyster, et al., “Follicular Stromal Cells and Lymphocyte Homing to Follicles”, Immunological Reviews, vol. 176, pp. 181-193 (2000).
D'Amico et al., Blood 92:207-214 (1998).
Danke, et al., “HLA Class II-Restricted CD4+ T Cell Responses Directed Against Influenza Viral Antigens Postinfluenza Vaccination”, The Journal of Immunology, vol. 171, pp. 3163-3169 (2003).
Denkbas, et al., “Magnetic Chotosan Microspheres: Preparation and Characterization”, Reactive & Functional Polymers, vol. 50, pp. 225-232 (2002).
Dubey et al. (2005)J. Clin. Endocrin&Met., 90, 247-255.
Dubois, et al., “Dendritic Cells Enhance Growth and Differentiation of CD40-Activated B Lymphocytes”, J. Exp. Med., vol. 185, pp. 941-951 (1997).
Dubois et al., J. Leukocyte Biology, 1999, v.66, p. 224-230.
Edelman et al, A Cultureal Renaissance: In Vitro Cell Biology Embraces Three-Dimensional Context. Exp Neurol. 2005, vol. 192, pp. 1-6.
El Shikh, M. et al., “Follicular Dendritic Cells Stimulated by Collagen Type I Develop Dendrites and Networks In Vitro,” Cell and Tissue Research, (2007), 329(1), pp. 81-89.
Forster, et al., “CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs”, Cell., vol. 99, pp. 23-33 (1999).
Fransson, et al., “Culture of Human Epidermal Lang
Drake, III Donald
Mishkin Eric
Moser Janice
Singh Inderpal
Song Haifeng
Belyavskyi Michail
Roylance Abrams Berdo & Goodman L.L.P.
Sanofi Pasteur Vaxdesign Corp.
LandOfFree
Method for determining the immunogenicity of an antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the immunogenicity of an antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the immunogenicity of an antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4314257